SEC Filing Summary

Gabrielle Sulzberger, a director at Eli Lilly & Co (LLY), acquired 5.39 shares of common stock on April 20, 2026, at a price of $919.9 per share. These shares were acquired under the Lilly Directors' Deferral Plan in lieu of cash compensation and will be settled in shares following her separation from service. Following this transaction, Sulzberger directly owns 2981.599 shares of Eli Lilly common stock.